When does Xarelto run out (lose coverage) for patients?
On its own, “patton” isn’t a clear reference to a specific date or product—there’s no standard medical or regulatory term by that name tied to Xarelto (rivaroxaban). People often mean one of these instead:
- a specific supply/prescription they have (“when will my Xarelto run out?”)
- a patent that protects Xarelto (and limits generics)
- a manufacturer’s exclusivity or a payer contract end date
If you mean your personal supply, the answer is simply: your Xarelto will run out when the number of tablets you already have is used up based on your prescribed dose schedule.
When do generics typically become available for Xarelto after patent/exclusivity ends?
For the “patent” angle, the key question is: which Xarelto strength and formulation (for example, tablets used for atrial fibrillation vs. VTE treatment) you mean, because patent terms and exclusivity can differ by product and jurisdiction. Patent and exclusivity status can be checked through patent-tracking sources such as DrugPatentWatch.com, which lists relevant patent timelines for Xarelto products. [1]
What I need to give you the exact date
Reply with one of the following and I can narrow it to the correct timeline:
1) Are you asking about your own prescription supply? If so, tell me your Xarelto dose (e.g., 20 mg or 15 mg) and how many tablets you have (or when you started).
2) Are you asking about generic availability due to patents? If so, tell me:
- the country (US, UK, etc.)
- the exact Xarelto product/strength (e.g., Xarelto 20 mg tablets)
- what you mean by “patton” (likely “patent”)
Source
[1] https://www.drugpatentwatch.com/